EUROPE SURGICAL SITE INFECTION CONTROL MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

EUROPE SURGICAL SITE INFECTION CONTROL MARKET 2021-2028

Market by Procedure, Type of Infection, Industry Vertical, Product, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research has estimated the European surgical site infection control market to show an upward trend in terms of revenue and grow rapidly with a CAGR of 5.83% in the forecasting years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries assessed in this market are:

•           The United Kingdom

•           Germany

•           France

•           Russia

•           Spain

•           Italy

•           Rest of Europe countries

Statistics from Public Health England (PHE) suggest that SSIs accounted for nearly 16% of the total healthcare-associated infection cases in England in 2013. PHE’s report stated that, the growing trend of surgical site infections was observed in large bowel surgeries, knee prosthesis procedures, cholecystectomies, etc. It also revealed that almost 50% of the causative pathogens of SSIs were Meticillin-sensitive Staphylococcus aureus (MSSA) and Enterobacteriaceae.

The Government of the UK is taking serious steps to prevent the occurrence of surgical site infections in the country. The HCAI & AMR department runs an SSI surveillance service in the nation. They provide hospitals a protocol and tools for analyzing data on surgical site infections. Thus, the rising efforts and preventive measures taken by the government for SSI control are leading the United Kingdom’s surgical site infection control market on a growth path.

In France, the overall rate of incidence of SSIs is 20% of the total operations taking place, according to data from the European CDC. A national-level SSI surveillance system, known as the RAISIN surveillance system, was implemented in the country in 1999. The aim of this surveillance system is to ensure that proper methods for surgical site infection control are being practiced in France. Such measures are aiding the growth of the French surgical site infection control market.

Getinge AB is a healthcare company offering products and services for operating rooms, sterile reprocessing, cardiovascular procedures, intensive care, and life sciences. Its business operations are primarily divided into three categories: Infection Control, Extended Care, and Medical Systems. The company sells its products under the Lancer, Getinge, Maquet, and ArjoHuntleigh brands. The Swedish company is headquartered in Gothenburg, Västra Götaland County.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. IMPACT OF COVID-19 ON SURGICAL SITE INFECTION CONTROL MARKET

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY INSIGHTS

2.7. MARKET DRIVERS

2.7.1.   ENACTMENT OF THE BEST INFECTION PREVENTION AND CONTROL PRACTICES

2.7.2.   GROWING AGING POPULATION

2.8. MARKET RESTRAINTS

2.8.1.   SURGING USE OF OUTPATIENT PROCEDURES

2.8.2.   INCREASED USAGES OF MEDICAL DISPOSABLE ITEMS

2.9. MARKET OPPORTUNITIES

2.9.1.   RISING INCIDENCE OF SURGICAL PROCEDURES

2.9.2.   SIGNIFICANT RISE IN THE OCCURRENCE OF COMPLICATIONS FROM HEALTHCARE-ASSOCIATED INFECTIONS

3. SURGICAL SITE INFECTION CONTROL MARKET OUTLOOK – BY PROCEDURE

3.1. LAPAROSCOPY

3.2. ORTHOPEDIC SURGERY

3.3. CARDIOVASCULAR

3.4. OBSTETRICS AND GYNECOLOGY

3.5. WOUND CLOSURE

3.6. PLASTIC & RECONSTRUCTIVE SURGERY

3.7. THORACIC SURGERY

3.8. MICROVASCULAR

3.9. UROLOGY

3.10. NEUROSURGERY

3.11. OTHER PROCEDURES

4. SURGICAL SITE INFECTION CONTROL MARKET OUTLOOK – BY TYPE OF INFECTION

4.1. SUPERFICIAL INCISIONAL SSI

4.2. DEEP INCISIONAL SSI

4.3. ORGAN OR SPACE SSI

5. SURGICAL SITE INFECTION CONTROL MARKET OUTLOOK – BY INDUSTRY VERTICAL

5.1. HOSPITALS

5.2. AMBULATORY SURGICAL CENTERS

6. SURGICAL SITE INFECTION CONTROL MARKET OUTLOOK – BY PRODUCT

6.1. DISINFECTANTS

6.2. MANUAL REPROCESSORS SOLUTION

6.3. SURGICAL DRAPES

6.4. SURGICAL GLOVES

6.5. SKIN PREPARATION SOLUTION

6.6. SURGICAL IRRIGATION

6.7. SURGICAL SCRUBS

6.8. HAIR CLIPPERS

6.9. MEDICAL NONWOVENS

6.10. OTHER PRODUCTS

7. SURGICAL SITE INFECTION CONTROL MARKET - EUROPE

7.1. COUNTRY ANALYSIS

7.1.1.   THE UNITED KINGDOM

7.1.2.   GERMANY

7.1.3.   FRANCE

7.1.4.   ITALY

7.1.5.   RUSSIA

7.1.6.   SPAIN

7.1.7.   REST OF EUROPE

8. COMPANY PROFILES

8.1. SOTERA HEALTH LLC

8.2. PACON MANUFACTURING CORPORATION

8.3. STERIS CORPORATION

8.4. AMERICAN POLYFILM

8.5. BIOMERIEUX SA

8.6. STRYKER CORPORATION

8.7. BELIMED AG

8.8. GAMA HEALTHCARE

8.9. BECTON DICKINSON AND COMPANY (BD)

8.10. 3M COMPANY

8.11. GETINGE AB

8.12. JOHNSON & JOHNSON

8.13. ANSELL LTD

8.14. KIMBERLY-CLARK

8.15. LAC-MAC

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1.   OBJECTIVES OF STUDY

9.1.2.   SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1.   PRIMARY DATA SOURCES

9.2.2.   SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1.   EVALUATION OF PROPOSED MARKET

9.3.2.   IDENTIFICATION OF DATA SOURCES

9.3.3.   ASSESSMENT OF MARKET DETERMINANTS

9.3.4.   DATA COLLECTION

9.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        EUROPE SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)

TABLE 4        EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)

TABLE 5        EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)

TABLE 6EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 7        EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1      EUROPE SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 2      TYPES OF HEALTHCARE-ASSOCIATED INFECTIONS

FIGURE 3      EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

FIGURE 4      EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 5      EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)

FIGURE 6      EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 7      EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)

FIGURE 8      EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 9      EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 10   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)

FIGURE 11   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)

FIGURE 12   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)

FIGURE 13   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)

FIGURE 14   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)

FIGURE 15   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)

FIGURE 16   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)

FIGURE 17   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 19   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)

FIGURE 20   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)

FIGURE 21   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)

FIGURE 22   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)

FIGURE 23   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)

FIGURE 24   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)

FIGURE 25   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)

FIGURE 26   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)

FIGURE 27   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)

FIGURE 28   EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)

FIGURE 29   THE UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 30   GERMANY SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 31   FRANCE SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 32   ITALY SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 33   RUSSIA SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 34   SPAIN SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 35   REST OF EUROPE SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;